SELLAS Life Sciences Group, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
SELLAS Life Sciences Group, Inc. (SLS) had Convertible Preferred Stock, Shares Issued upon Conversion of 74.96 thousand shares as of 2018-07-16, per its 10-K filed 2020-03-13.
Discontinued › Notes › Equity › Stockholders' Equity Note › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2020-03-13
- 2018-07-16: Convertible Preferred Stock, Shares Issued upon Conversion 74.96K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 3.75M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2018-07-16 | 74.96K shares 10-K · filed 2020-03-13 | 3.75M shares 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |